Header Logo

Connection

NAVEEN PEMMARAJU to Patient Safety

Back to Details
This is a "connection" page, showing publications NAVEEN PEMMARAJU has written about Patient Safety.
NAVEEN PEMMARAJU
Connection Strength
0.104
Patient Safety
  1. Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study. Lancet Oncol. 2018 02; 19(2):240-248.
    View in: PubMed
    Score: 0.104
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.